CMS Hydrophilic Contact Lenses Coverage Policy Update (NCD 233): What Billing Teams Need to Know

CMS has modified National Coverage Determination (NCD) 233, governing Medicare coverage of hydrophilic contact lenses. The update clarifies the conditions under which these lenses qualify for reimbursement under the prosthetic device benefit — and reaffirms a firm coverage exclusion for a broad range of refractive conditions. If your practice bills Medicare for contact lens-related services, understanding this distinction is essential to avoiding denials.

What CMS NCD 233 Covers — and What It Doesn't

The core tension in NCD 233 has always been between Medicare's statutory exclusion for eyeglasses and the prosthetic device benefit. CMS's position under this modified policy is clear: hydrophilic contact lenses are classified as eyeglasses under §1862(a)(7) of the Social Security Act. That classification triggers the general exclusion from Medicare coverage in most circumstances.

However, there is a meaningful carve-out. When hydrophilic contact lenses are prescribed for an aphakic patient — someone who has had the natural lens of the eye removed, typically following cataract surgery — Medicare may cover them under the prosthetic device benefit category. This is a narrow, diagnosis-driven exception, not a general allowance for contact lenses.

The policy also cross-references §80.1, which addresses coverage of a hydrophilic lens used as a corneal bandage. That represents a second, distinct pathway to coverage that billing teams should track separately from the aphakic patient provision.

CMS Coverage Criteria for Hydrophilic Contact Lenses Under the Prosthetic Device Benefit

To qualify for Medicare reimbursement under NCD 233, the following criteria apply:

Covered: Hydrophilic contact lenses prescribed for aphakic patients. These are payable under the prosthetic device benefit because the lens is replacing the function of the eye's natural crystalline lens — not merely correcting a refractive error in an otherwise healthy eye.

Not Covered: Hydrophilic contact lenses used for any of the following conditions in non-diseased eyes:

Medicare Administrative Contractors (MACs) are authorized to accept a Food and Drug Administration (FDA) letter of approval or other FDA-published material as evidence of FDA approval for a given lens. This means your documentation package for a covered claim may need to include FDA approval documentation in addition to the standard medical necessity records.

CMS Benefit Category and Cross-Reference Guidance

NCD 233 sits under the Prosthetic Devices benefit category. CMS notes this may not be exhaustive — meaning documentation should explicitly establish why the item qualifies under that benefit, not just reference it by name.

The policy cross-references two sections of the Medicare Benefit Policy Manual:

• Chapter 15, §100 and §120 — Covered Medical and Other Health Services
• Chapter 16, §20 and §90 — General Exclusions from Coverage

Billing teams and compliance officers should review these manual sections directly. Chapter 16 in particular governs the eyeglass exclusion framework and will inform how MACs adjudicate borderline claims.

Affected Codes

This policy does not list specific CPT or HCPCS codes. Per the policy data for NCD 233, no codes are enumerated in the current version of this NCD. This is consistent with how some CMS coverage determinations function — the policy establishes coverage rules and medical necessity criteria, while specific coding guidance may reside in MAC local policies or claims processing instructions.

Billing teams should consult their regional MAC for applicable HCPCS codes related to hydrophilic contact lenses (particularly in the V-code range used for vision-related prosthetics) and for corneal bandage lens claims under §80.1. Do not assume a code is covered simply because it exists in your encoder — tie every claim back to the coverage criteria in NCD 233.

Prior Authorization and FDA Documentation Requirements

NCD 233 does not specify a prior authorization requirement. However, given the narrow covered indication (aphakia) and the explicit statutory exclusion for refractive conditions, medical necessity documentation is critical at the point of claim submission. Every claim should include:

1. A clear diagnosis establishing aphakia or the applicable corneal condition (if billing under the bandage lens provision)
2. The prescribing physician's written order
3. FDA approval documentation for the specific lens, if requested by the MAC

Submitting without these elements is a common reason for denial on these claims, even when the clinical indication is legitimate.

What Your Billing Team Should Do